Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy.
Raphaël LejoyeuxFrancine Behar-CohenIrmela MantelJorge Ruiz-MedranoSarah MrejenRamin TadayoniAlain GaudricElodie BousquetPublished in: Eye (London, England) (2021)
Fluid resorption was incomplete in about half of the patients with MNV secondary to CSCR after anti-VEGF injections. Shallower SRD or the presence of SHRM were predictors of poor response to anti-VEGF.